ACADACADIA Pharmaceuticals Inc.Healthcare · Biotechnologyas of 2026-09-25
Horizon

Issued 2026-09-25 at $20.68 · now $20.68 (2026-09-25, +0.0% since)

Based on its own history, a month from the 2026-09-25 close, ACAD has typically landed between $16.90 and $25.51 — a range of −18.3% to +23.3% from the issuance price $20.68.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

5,003 overlapping 1 month windows · 2006-09-26 – 2026-08-26 · basis climatology · forecast (batch). Base rate up 53.7% (90% CI 51.5–55.9%, ≈1,391 obs). Not a call on this stock — we have no evidence its odds differ.

The cone is anchored at the 2026-09-25 issuance close ($20.68) — the price the forecast resolves against on 2026-10-26, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where ACAD has typically landed a month from the 2026-09-25 close of $20.68 — the range is history, not a prediction.

$16.9worst · -18.3%$25.51best · +23.3%
  • now $20.68 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $20.8 (+0.6%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $18.89–$22.72
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $16.9–$25.51
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 5,003 windows spanning 2006-09-26 to 2026-09-25. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2009-08-31−72.9%−72.9%+0.0%
2009-08-27−71.4%−71.4%+0.0%
2009-08-28−71.4%−71.4%+0.0%
3 best
2009-07-15+191.0%+0.0%+191.0%
2009-07-16+181.4%+0.0%+181.4%
2009-07-10+166.7%+0.0%+166.7%

5,003 overlapping windows · 2006-09-26 – 2026-09-25 · not cherry-picked

Pending catalysts

  • August 2027 — Trial primary completion: Phase 2 primary completion: ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response (source, as of 2026-08-14)
  • January 2028 — Trial primary completion: Phase 2/Phase PHASE3 primary completion: ACP-204 in Adults With Alzheimer's Disease Psychosis (source, as of 2026-08-14)
  • February 2028 — Trial primary completion: Phase 2 primary completion: Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis (source, as of 2026-08-14)
  • February 2029 — Trial primary completion: Phase 3 primary completion: Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis (source, as of 2026-08-14)
  • April 2029 — Trial primary completion: Phase 3 primary completion: ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study (source, as of 2026-08-14)
  • May 2029 — Trial primary completion: Phase 3 primary completion: OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome (source, as of 2026-08-14)

Public, scheduled events — dated attention, not a prediction of the outcome. See the FDA catalysts page for the historical base rate.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
45%
+4.6%
n=20
Feb
60%
+1.5%
n=20
Mar
40%
+5.6%
n=20
Apr
45%
+1.0%
n=20
May
55%
+5.9%
n=20
Jun
60%
+0.6%
n=20
Jul
60%
+6.5%
n=20
Aug
50%
+0.2%
n=20
Sep
45%
−0.8%
n=20
Oct
50%
−2.3%
n=20
Nov
50%
+4.9%
n=20
Dec
55%
+5.9%
n=20

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$31$202026-08-06: 2 insider sales, $418K — Schneyer Mark C. …2026-08-05: 1 insider sale, $170K — Schneyer Mark C.2026-07-30: 2 insider sales, $433K — Thompson Elizabeth H.Z. …2026-06-26: 1 insider sale, $298K — Kihara James2026-05-26: 1 insider sale, $114K — Kihara James2026-05-04: 2 insider sales, $105K — Schneyer Mark C., Kihara James2026-04-07: 2 insider sales, $83K — Schneyer Mark C., Kihara James2026-03-26: 4 insider sales, $93K — Schneyer Mark C., Kihara James …2026-03-25: 5 insider sales, $514K — Owen Adams Catherine, Schneyer Mark C., Rhodes Jennifer J, Thompson Elizabeth H.Z. …2026-02-09: 1 insider sale, $162K — Rhodes Jennifer J2025-11-18: 2 insider sales, $340K — Schneyer Mark C., Kihara James2025-11-10: 1 insider sale, $671K — Daly James M2025-09-15: 1 insider sale, $83K — Schneyer Mark C.2025-09-02: 1 insider sale, $42K — GAROFALO ELIZABETH A.2025-08: 1 open-market sale, $554K2025-09: 2 open-market sales, $124K2025-11: 3 open-market sales, $1.0M2026-02: 1 open-market sale, $162K2026-03: 9 open-market sales, $607K2026-04: 2 open-market sales, $83K2026-05: 3 open-market sales, $220K2026-06: 1 open-market sale, $298K2026-07: 2 open-market sales, $433K2026-08: 3 open-market sales, $587K↑ buys↓ salesofficer Schneyer Mark C. — Sale on 2026-08-06, filed 1 day after the tradeofficer Schneyer Mark C. — Sale on 2026-08-06, filed 1 day after the tradeofficer Schneyer Mark C. — Sale on 2026-08-05, filed 2 days after the tradedirector Thompson Elizabeth H.Z. — Sale on 2026-07-30, filed 1 day after the tradedirector Thompson Elizabeth H.Z. — Sale on 2026-07-30, filed 1 day after the tradeofficer Kihara James — Sale on 2026-06-26, filed 3 days after the tradeofficer Kihara James — Sale on 2026-05-26, filed 1 day after the tradeofficer Schneyer Mark C. — Sale on 2026-05-04, filed 1 day after the tradeofficer Kihara James — Sale on 2026-05-04, filed 1 day after the tradeofficer Schneyer Mark C. — Sale on 2026-04-07, filed same dayofficer Kihara James — Sale on 2026-04-07, filed same dayofficer Schneyer Mark C. — Sale on 2026-03-26, filed same dayofficer Kihara James — Sale on 2026-03-26, filed same dayofficer Schneyer Mark C. — Sale on 2026-03-26, filed same dayofficer Kihara James — Sale on 2026-03-26, filed same daydirector Owen Adams Catherine — Sale on 2026-03-25, filed 1 day after the tradeofficer Schneyer Mark C. — Sale on 2026-03-25, filed 1 day after the tradeofficer Rhodes Jennifer J — Sale on 2026-03-25, filed 1 day after the tradedirector Thompson Elizabeth H.Z. — Sale on 2026-03-25, filed 1 day after the tradeofficer Kihara James — Sale on 2026-03-25, filed 1 day after the tradeofficer Rhodes Jennifer J — Sale on 2026-02-09, filed 1 day after the tradeofficer Schneyer Mark C. — Sale on 2025-11-18, filed 1 day after the tradeofficer Kihara James — Sale on 2025-11-18, filed 1 day after the tradedirector Daly James M — Sale on 2025-11-10, filed 2 days after the tradeofficer Schneyer Mark C. — Sale on 2025-09-15, filed 1 day after the tradedirector GAROFALO ELIZABETH A. — Sale on 2025-09-02, filed 1 day after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-08-06Schneyer Mark C.officerSale9,292 @ $29.34$273K−12.0% of holding−1.7%not yet — horizon still open67,828Form 4 · filed 1 day after the trade
2026-08-06Schneyer Mark C.officerSale5,000 @ $29.00$145K−6.1% of holding−1.7%not yet — horizon still open77,120Form 4 · filed 1 day after the trade
2026-08-05Schneyer Mark C.officerSale5,849 @ $29.00$170K−7.9% of holding−3.7%not yet — horizon still open67,828Form 4 · filed 2 days after the trade
2026-07-30Thompson Elizabeth H.Z.directorSale16,508 @ $26.13$431K−46.4% of holding+5.9%not yet — horizon still open19,044Form 4 · filed 1 day after the trade
2026-07-30Thompson Elizabeth H.Z.directorSale50 @ $26.17$1K−0.3% of holding+5.9%not yet — horizon still open18,994Form 4 · filed 1 day after the trade
2026-06-26Kihara JamesofficerSale11,421 @ $26.08$298K−46.6% of holding+1.1%not yet — horizon still open13,088Form 4 · filed 3 days after the trade
2026-05-26Kihara JamesofficerSale5,401 @ $21.18$114K−18.1% of holding+13.5%not yet — horizon still open24,509Form 4 · filed 1 day after the trade
2026-05-04Schneyer Mark C.officerSale3,506 @ $21.79$76K−5.0% of holding−8.5%not yet — horizon still open66,145Form 4 · filed 1 day after the trade
2026-05-04Kihara JamesofficerSale1,332 @ $21.79$29K−4.4% of holding−8.5%not yet — horizon still open29,129Form 4 · filed 1 day after the trade
2026-04-07Schneyer Mark C.officerSale2,709 @ $22.20$60K−4.1% of holding−14.1%not yet — horizon still open62,836Form 4 · filed same day
2026-04-07Kihara JamesofficerSale1,030 @ $22.20$23K−3.6% of holding−14.1%not yet — horizon still open27,865Form 4 · filed same day
2026-03-26Schneyer Mark C.officerSale3,171 @ $21.65$69K−5.0% of holding−7.0%−23.6%60,306Form 4 · filed same day
2026-03-26Kihara JamesofficerSale1,097 @ $21.65$24K−3.9% of holding−7.0%−23.6%26,897Form 4 · filed same day
2026-03-26Schneyer Mark C.officerSale37 @ $21.72$804−0.1% of holding−7.0%−23.6%60,269Form 4 · filed same day
2026-03-26Kihara JamesofficerSale12 @ $21.73$261−0.0% of holding−7.0%−23.6%26,885Form 4 · filed same day
2026-03-25Owen Adams CatherinedirectorSale11,641 @ $21.47$250K−44.0% of holding−8.9%−16.3%14,803Form 4 · filed 1 day after the trade
2026-03-25Schneyer Mark C.officerSale4,177 @ $21.47$90K−6.8% of holding−8.9%−16.3%57,299Form 4 · filed 1 day after the trade
2026-03-25Rhodes Jennifer JofficerSale3,844 @ $21.47$83K−25.4% of holding−8.9%−16.3%11,280Form 4 · filed 1 day after the trade
2026-03-25Thompson Elizabeth H.Z.directorSale3,435 @ $21.47$74K−51.2% of holding−8.9%−16.3%3,280Form 4 · filed 1 day after the trade
2026-03-25Kihara JamesofficerSale833 @ $21.47$18K−3.1% of holding−8.9%−16.3%25,852Form 4 · filed 1 day after the trade
2026-02-09Rhodes Jennifer JofficerSale6,950 @ $23.38$162K−47.7% of holding−2.8%+15.0%7,609Form 4 · filed 1 day after the trade
2025-11-18Schneyer Mark C.officerSale10,262 @ $23.69$243K−16.1% of holding+9.3%−23.6%53,338Form 4 · filed 1 day after the trade
2025-11-18Kihara JamesofficerSale4,084 @ $23.69$97K−14.0% of holding+9.3%−23.6%25,058Form 4 · filed 1 day after the trade
2025-11-10Daly James MdirectorSale30,000 @ $22.37$671K−88.1% of holding+19.9%−9.6%4,041Form 4 · filed 2 days after the trade
2025-09-15Schneyer Mark C.officerSale3,498 @ $23.65$83K−7.5% of holding−17.9%−17.4%43,447Form 4 · filed 1 day after the trade
2025-09-02GAROFALO ELIZABETH A.directorSale1,600 @ $25.98$42K−5.9% of holding−22.0%−16.6%25,382Form 4 · filed 1 day after the trade
2025-08-18Schneyer Mark C.officerSale22,000 @ $25.18$554K−35.4% of holding−5.9%−14.7%40,130Form 4 · filed 1 day after the trade
2025-06-04Brege LauradirectorSale14,446 @ $21.78$315K−48.9% of holding−8.5%+3.5%15,095Form 4 · filed 1 day after the trade
2025-05-16Kihara JamesofficerSale2,000 @ $25.00$50K−8.2% of holding+1.9%−5.8%22,395Form 4 · filed 3 days after the trade
2025-05-16Schneyer Mark C.officerSale2,000 @ $25.00$50K−3.1% of holding+1.9%−5.8%62,130Form 4 · filed 3 days after the trade
2025-05-16Kihara JamesofficerSale2,000 @ $20.00$40K−8.9% of holding+1.9%−5.8%20,395Form 4 · filed 3 days after the trade
2025-05-02Schneyer Mark C.officerSale3,498 @ $14.60$51K−5.3% of holding+42.2%+31.2%62,773Form 4 · filed same day
2025-05-02Kihara JamesofficerSale1,327 @ $14.60$19K−5.3% of holding+42.2%+31.2%23,526Form 4 · filed same day
2025-04-08Schneyer Mark C.officerSale2,708 @ $14.82$40K−4.4% of holding+6.3%+14.8%59,456Form 4 · filed same day
2025-04-08Kihara JamesofficerSale1,028 @ $14.82$15K−4.4% of holding+6.3%+14.8%22,257Form 4 · filed same day
2025-03-26Schneyer Mark C.officerSale3,171 @ $17.05$54K−5.3% of holding−10.3%+8.1%56,889Form 4 · filed same day
2025-03-26Kihara JamesofficerSale1,095 @ $17.05$19K−4.9% of holding−10.3%+8.1%21,275Form 4 · filed same day
2025-03-05GAROFALO ELIZABETH A.directorSale4,919 @ $18.23$90K−21.8% of holding−3.2%+29.0%17,595Form 4 · filed 1 day after the trade
2025-02-24Schneyer Mark C.officerSale773 @ $19.96$15K−1.4% of holding−8.8%+21.8%53,882Form 4 · filed 1 day after the trade
2025-02-24Kihara JamesofficerSale475 @ $19.96$9K−2.3% of holding−8.8%+21.8%20,228Form 4 · filed 1 day after the trade
2024-11-19Teehan BrendanofficerSale10,329 @ $16.81$174K−14.3% of holding+3.9%+36.9%62,105Form 4 · filed same day
2024-11-19Schneyer Mark C.officerSale10,259 @ $16.81$172K−16.1% of holding+3.9%+36.9%53,302Form 4 · filed same day
2024-11-19Kihara JamesofficerSale4,073 @ $16.81$68K−17.0% of holding+3.9%+36.9%19,863Form 4 · filed same day
2024-08-19DAVIS STEPHENdirectorSale31,747 @ $15.28$485K−14.5% of holding+3.3%+19.0%186,555Form 4 · filed 1 day after the trade
2024-08-19Schneyer Mark C.officerSale9,733 @ $15.28$149K−18.2% of holding+3.3%+19.0%43,735Form 4 · filed 1 day after the trade
2024-08-19Teehan BrendanofficerSale9,534 @ $15.28$146K−15.4% of holding+3.3%+19.0%52,177Form 4 · filed 1 day after the trade
2024-06-10Schneyer Mark C.officerSale975 @ $14.79$14K−2.7% of holding+14.4%+12.5%34,564Form 4 · filed 1 day after the trade
2024-05-02DAVIS STEPHENdirectorSale11,427 @ $16.94$194K−6.9% of holding−15.0%−27.9%155,231Form 4 · filed 1 day after the trade
2024-05-02Schneyer Mark C.officerSale3,503 @ $16.94$59K−9.9% of holding−15.0%−27.9%32,053Form 4 · filed 1 day after the trade
2024-05-02Teehan BrendanofficerSale3,477 @ $16.94$59K−7.6% of holding−15.0%−27.9%42,133Form 4 · filed 1 day after the trade
2024-05-02Kihara JamesofficerSale1,326 @ $16.94$22K−8.4% of holding−15.0%−27.9%14,370Form 4 · filed 1 day after the trade
2024-04-08DAVIS STEPHENdirectorSale17,716 @ $17.87$317K−10.9% of holding−2.8%−27.4%144,267Form 4 · filed 1 day after the trade
2024-04-08DAVIS STEPHENdirectorSale8,858 @ $17.87$158K−5.2% of holding−2.8%−27.4%161,983Form 4 · filed 1 day after the trade
2024-04-08Schneyer Mark C.officerSale2,716 @ $17.87$49K−8.6% of holding−2.8%−27.4%28,742Form 4 · filed 1 day after the trade
2024-04-08Teehan BrendanofficerSale2,568 @ $17.87$46K−6.2% of holding−2.8%−27.4%38,796Form 4 · filed 1 day after the trade
2024-04-08Kihara JamesofficerSale1,028 @ $17.87$18K−6.9% of holding−2.8%−27.4%13,862Form 4 · filed 1 day after the trade
2024-04-08Kihara JamesofficerSale762 @ $17.87$14K−5.5% of holding−2.8%−27.4%13,100Form 4 · filed 1 day after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

243 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-08-06Schneyer Mark C.officerOption exercise14,29282,120Form 4
2026-08-06Schneyer Mark C.officerOption exercise14,29260,423Form 4
2026-08-05Schneyer Mark C.officerOption exercise5,84973,677Form 4
2026-08-05Schneyer Mark C.officerOption exercise5,84974,715Form 4
2026-07-29Thompson Elizabeth H.Z.directorOption exercise32,27232,272Form 4
2026-07-29Thompson Elizabeth H.Z.directorOption exercise32,27235,552Form 4
2026-07-29Thompson Elizabeth H.Z.directorOption exercise32,27235,552Form 4
2026-05-29BAKER BROS. ADVISORS LPdirectorAward / grant32,00832,008Form 4
2026-05-29BAKER BROS. ADVISORS LPdirectorAward / grant18,6223,677,357Form 4
2026-05-29BAKER BROS. ADVISORS LPdirectorAward / grant18,62239,384,587Form 4
2026-05-29HARRIGAN EDMUNDdirectorOption exercise8,1070Form 4
2026-05-29HARRIGAN EDMUNDdirectorAward / grant16,00416,004Form 4
2026-05-29HARRIGAN EDMUNDdirectorAward / grant9,3119,311Form 4
2026-05-29Brege LauradirectorOption exercise8,1070Form 4
2026-05-29Brege LauradirectorAward / grant16,00416,004Form 4
2026-05-29Brege LauradirectorAward / grant9,3119,311Form 4
2026-05-29Daly James MdirectorOption exercise8,1070Form 4
2026-05-29Daly James MdirectorAward / grant16,00416,004Form 4
2026-05-29Daly James MdirectorAward / grant9,3119,311Form 4
2026-05-29Poole JonathandirectorOption exercise2,0100Form 4
2026-05-29Poole JonathandirectorAward / grant16,00416,004Form 4
2026-05-29Poole JonathandirectorAward / grant9,3119,311Form 4
2026-05-29GAROFALO ELIZABETH A.directorOption exercise8,1070Form 4
2026-05-29GAROFALO ELIZABETH A.directorAward / grant16,00416,004Form 4
2026-05-29GAROFALO ELIZABETH A.directorAward / grant9,3119,311Form 4
2026-05-29Ndu AdoradirectorOption exercise8,1070Form 4
2026-05-29Ndu AdoradirectorAward / grant16,00416,004Form 4
2026-05-29Ndu AdoradirectorAward / grant9,3119,311Form 4
2026-05-29HARRIGAN EDMUNDdirectorOption exercise8,10743,148Form 4
2026-05-29GAROFALO ELIZABETH A.directorOption exercise8,10733,489Form 4
2026-05-29Poole JonathandirectorOption exercise2,0102,010Form 4
2026-05-29Ndu AdoradirectorOption exercise8,10732,908Form 4
2026-05-29Daly James MdirectorOption exercise8,10712,148Form 4
2026-05-29Brege LauradirectorOption exercise8,10723,202Form 4
2026-05-29Poole JonathandirectorOption exercise2,0102,010Form 4
2026-05-29Brege LauradirectorOption exercise8,10723,202Form 4
2026-05-29Daly James MdirectorOption exercise8,10712,148Form 4
2026-05-29GAROFALO ELIZABETH A.directorOption exercise8,10733,489Form 4
2026-05-29HARRIGAN EDMUNDdirectorOption exercise8,10743,148Form 4
2026-05-29Ndu AdoradirectorOption exercise8,10732,908Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.